Caricamento...
Celiac plexus neurolysis in the management of unresectable pancreatic cancer: When and how?
Pancreatic cancer is the second most common abdominal cancer in North America with an estimated 20% resectability at diagnosis, and overall 5-year survival of 5%. Pain is common in pancreatic cancer patients with 70%-80% suffering substantial pain. Celiac plexus neurolysis (CPN) is a technique that...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Baishideng Publishing Group Co., Limited
2014
|
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3942823/ https://ncbi.nlm.nih.gov/pubmed/24605017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i9.2186 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|